Arkolith/Insider Trading/CGEM/Form 4

Michaelson Jennifer

Chief Scientific OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Feb 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$165K
Net Open-Market Flow
-$165K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Sell(S)8K$14.30$114K182K
Feb 20, 2026Option exercise(M)8K$4.30$34K190K
Feb 20, 2026Sell(S)4K$13.62$51K182K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)8K—$0125K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-064256) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cullinan Therapeutics, Inc.

Build

Ask your agent about CGEM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-064256"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cullinan Therapeutics, Inc.
over the last 90 days and cite the filings.